Medtronic is the global leader medical technology, alleviating pain, restoring health an extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies - every three seconds, another life is improved by a Medtronic product or therapy.
The company was founded in 1949 in Minneapolis, Minnesota, USA by Earl E. Bakken and Palmer J. Hermundslie. Medtronic has been present in Europe since 1967.
Medtronic has direct presence in most European countries. Major European facilities include: Europe & Central Asia Headquarters in Tolochenaz, Switzerland, European Operations Centre for distribution and shared services in Heerlen, The Netherlands, Bakken Research Centre in Maastricht, The Netherlands, Therapy and Procedure Training Centre in Tolochenaz, Switzerland, Swiss Manufacturing Operations in Tolochenaz, Switzerland and Vascular Manufacturing in Galway, Ireland.
Over 6000 employees in Europe.
Cardiac Rhythm Disease Management manages the full spectrum of cardiac rhythm disorders to improve long-term patient care. The solutions developed at Medtronic allow physicians to monitor and treat their patients' changing cardiac conditions throughout a lifetime. These developments include pacemakers to treat patients with bradycardia (too-slow heartbeat); implantable defibrillators to help patients with tachyarrhythmia (too-fast heartbeat); and diagnostic and monitoring innovations that diagnose heart-related syncope (unexplained fainting), just to name a few.
Neuromodulation offers innovative therapies for chronic pain, movement disorders, spasticity, overactive bladder and urinary retention, benign prostatic hyperplasia and gastroparesis. Medtronic developed and leads the field of neuromodulation, the targeted and regulated delivery of electrical pulses and pharmaceuticals to specific sites in the nervous system.
Spinal and Biologics offers products that treat a variety of disorders of the cranium and spine, including traumatically induced conditions, deformities and tumours. Through the introduction of a substitute for iliac crest bone harvest and Minimal Access Spinal Technologies, the business has distinguished itself as a global leader in less-invasive surgical techniques. It also develops a variety of image-guided surgical navigation systems.
Diabetes offers insulin pump therapy, continuous glucose monitoring systems, related disposable products and diabetes management software, making Medtronic a world leader in diabetes management.
CardioVascular develops products that are used throughout the vascular system and those used for arrested and beating heart bypass surgery. The business markets the industry’s broadest line of heart valve products for replacement and repair, plus auto-transfusion equipment and disposable devices for handling and monitoring blood during major surgery, as well as cardiac ablation devices to treat a variety of heart conditions. The business also offers products and therapies that treat a wide range of vascular diseases and conditions. These products include coronary, peripheral and neurovascular stents, stent graft systems for diseases and conditions throughout the aorta, and distal protection systems.
Ear Nose & Throat (ENT) develops and manufactures minimally invasive products and techniques that treat a wide range of ENT conditions. The business markets powered tissue-removal systems and other micro-endoscopy instruments, nerve monitoring systems, disposable fluid control products, image-guided surgery systems and a Ménière's disease therapy device.
Medtronic International Trading Sàrl
Route du Molliau 31
CH - 1131 Tolochenaz
Telephone: +41 (0)21 802 70 00
Fax: +41 (0)21 802 79 00